Reporting J1444 under ESRD PPS
- By Renee Dustman
- In Coding
- May 2, 2019
- No Comments
In the quarterly update to the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS), a new HCPCS Level II code is being added for anemia management with an effective date of July 1, 2019.
J1444 Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron
This code is subject to Medicare Part B consolidated billing and, therefore, ESRD facilities will not receive separate payment for J1444 with or without modifier AY Item or service furnished to an ESRD patient that is not for the treatment of ESRD.
As will all drugs and biologicals that are furnished to ESRD patients via dialysate solution, append modifier JE Administered via dialysate to J1444 on bill type 72x.
MLN Matters MM11215
Renee Dustman
Executive Editor at AAPC
Renee Dustman, BS, AAPC MACRA Proficient, is an executive editor at AAPC. She holds a Bachelor of Science degree in Media Communications - Journalism. Renee has more than 20 years experience in print production and content management. Follow her on Twitter @dustman_aapc.
Latest posts by Renee Dustman (see all)
- Add These OIG Watch Items to Your Audit List - October 18, 2019
- Final Rule Revises Discharge Planning Requirements - October 10, 2019
- Scary Good Advice for Medical Coders and Billers - September 13, 2019
Leave a Reply